Routine share withholding; mechanical by default.
Signed Jan 26, 2026 · Updated Jan 26, 2026
The Department of Defense placed a delivery order for $9,048 of naloxone vials from Pfizer on January 26, 2026. This order was made under an existing agreement and was open to any bidder, making it a routine purchase rather than a unique or unusual transaction.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
$9,048
Actual federal dollars obligated to date on this award
$9,048
A maximum, not earned revenue
$652K across 10 awards
Obligations to date on awards newly signed in the last 12 months, mapped to this company
83.2% from the largest awarding agency
Share of T12M mapped obligations
#6 of 10 mapped awards by obligations
Within the awards OQRO has ingested
0.00% of FY2021 revenue ($81.3B)
T12M mapped obligations ÷ revenue the company reported in its 10-K. A size comparison: obligations are not revenue and are usually earned over several years
verified alias
Exact identifier > verified alias > manual override
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
4570864089!protonix dr 40 mg tablet 90s
The Department of Defense placed a delivery order for $8.2K of Pfizer's Protonix DR 40 MG tablets. This order was made under an existing larger agreement and was open to any bidder, making it a routine purchase.